Lonza · 20 hours ago
QA PM I-Operations
Lonza is a global leader in life sciences, and they are seeking a QA PM I in their Portsmouth, NH site. This role is key in supporting customers and internal teams by ensuring quality and compliance standards are met, while collaborating across diverse functions to contribute to the delivery of life-changing therapies.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Serve as the primary QA liaison for assigned external customers
Support change controls, deviations, investigations, CAPAs and quality‑related documentation
Lead Joint Quality Team meetings and track actions, minutes and KPIs
Collaborate with MSAT, Manufacturing, Engineering and QC teams
Review quality documents such as Quality Agreements and Product Quality Reviews
Ensure sound scientific justification and data integrity across quality records
Support customer audits and routine quality activities
Qualification
Required
Bachelor's degree in a scientific discipline or equivalent experience
Experience working in a GMP environment
Foundational understanding of quality assurance principles
Strong communication and collaboration skills
Ability to manage multiple priorities effectively
Attention to detail and a mindset focused on continuous improvement
Ability to build strong working relationships with internal teams and external partners
Benefits
Medical, dental and vision insurance.
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
H1B Sponsorship
Lonza has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Recent News
NH Business Review
2026-01-17
Company data provided by crunchbase